Dexamethasone reduces oxygen induced retinopathy in a mouse model

Pediatric Research

Volumn 46, Issue 1, 1999, Pages 94-100

  Rotschild, Tomas ^a   Nandgaonkar, Bharat N ^a   Yu, Kim ^a   Higgins, Rosemary D ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HYPEROXIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETINA NEOVASCULARIZATION; RETINOPATHY; SUBCUTANEOUS DRUG ADMINISTRATION; WEIGHT GAIN;

EID: 0033022306     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-199907000-00016     Document Type: Article

References (61)

1. Terry TL 1942 Extreme prematurity and fibroplastic overgrowth of persistent sheath behind each crystalline lens. Am J Ophthalmol 25:203-204
2. Casey Eye Institute 1996 Multicenter trial of cryotherapy for retinopathy of prematurity: snellen visual acuity and structural outcome at 5:1/2 years after randomization. Arch Ophthalmol 114:417-424
3. Gilbert C, Rahi J, Eckstein M, O'Sullivan J, Foster A 1997 Retinopathy of prematurity in middle-income countries. Lancet 350:12-14
4. Kennedy J, Todd DA, Watts J, John E 1997 Retinopathy of prematurity in infants less than 29 weeks gestation: 31/2 years pre-and postsurfactant. J Pediatr Ophthalmol Strabismus 34:289-292
5. Cryotherapy for retinopathy of prematurity cooperative group 1988 Multicenter trial of cryotherapy for retinopathy of prematurity: preliminary results. Arch Ophthalmol 106:471-479
6. McNamara JA, Tasman W, Brown GC, Federman JL 1991 Laser photocoagulation for stage 3+ retinopathy of prematurity. Ophthalmology 98:576-580
7. Preslan MW 1993 Laser therapy for retinopathy of prematurity. J Pediatr Ophthalmol Strabismus 30:80-83
8. Landers MB, Toth CA, Semple HC, Morse LS 1992 Treatment of retinopathy of prematurity with argon laser photocoagulation. Arch Ophthalmol 110:44-47
9. Cummings JJ, D'Eugenio DB, Gross SJ 1989 A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia. N Engl J Med 320:1505-1510
10. Collaborative dexamethasone trial group 1991 Dexamethasone therapy in neonatal chronic lung disease: an international placebo-controlled trial. Pediatrics 88:421-427
11. Durand M, Sardesai S, McEvoy C 1995 Effects of early dexamethasone therapy on pulmonary mechanics and chronic lung disease in very low birth weight infants: a randomized, controlled trial. Pediatrics 95:584-590
12. Avery GB, Fletcher AB, Kaplan M, Brudno DS 1985 Controlled trial of dexamethasone in respiratory-dependent infants with bronchopulmonary dysplasia. Pediatrics 75:106-111
13. Harkavy KL, Scanlon JW, Chowdhry PK, Grylack LJ 1989 Dexamethasone therapy for chronic lung disease in ventilator and oxygen-dependent infants: a controlled trial. J Pediatr. 115:979-983
14. Kazzi NJ, Brans YW, Poland RL 1990 Dexamethasone effects on the hospital course of infants with bronchopulmonary dysplasia who are dependent on artificial ventilation. Pediatrics 86:722-727
15. Yeh TF, Torre JF, Rastogi A, Anyebuno MA, Pildes RS 1990 Early postnatal dexamethasone therapy in premature infants with severe respiratory distress syndrome: a double-blind, controlled study. J Pediatr 117:273-282
16. Papile LA, Tyson JE, Stoll BJ, Wright LL, Donovan EF, Bauer CR, Krause-Steinrauf H, Verter J, Korones SB, Lemons JA, Fanaroff AA, Stevenson DK 1998 A multicenter trial of two dexamethasone regiments in ventilator-dependent premature infants. N Engl J Med 338:1112-1118
17. La Motte W, Tyner GS, Scheie HG 1952 Treatment of retrolental fibroplasia with vitamin E, Corticotropin (ACTH), and cortisone. Arch Ophthalmol 47:556-569
18. Batton DG, Roberts C, Trese M, Maisels J 1992 Severe retinopathy of prematurity and steroid exposure. Pediatrics 90:534-536
19. Reese AB, Blodi FC, Locke KC, Silverman WA, Day RL 1952 Results of use of corticotropin (ACTH) in treatment of retrolental fibroplasia. Arch Ophthalmol 47:551-555
20. Ramanathan R, Siassi B, deLemos RA 1995 Severe retinopathy of prematurity in extremely low birth weight infants after short-term dexamethasone therapy. J Perinatol 15:178-182
21. Sobel DB, Philip AG 1992 Prolonged dexamethasone therapy reduces the incidence of cryotherapy for retinopathy of prematurity in infants less then 1 kilogram birth weight with bronchopulmonary dysplasia. Pediatrics 90:529-533
22. Todd DA, Kennedy J, Roberts S, Watts J, Psaila K, John E 1994 Retinopathy of prematurity in infants less than 29 wk' gestation at birth. Aust N Z J Ophthalmol 22:19-23
23. Wright K, Wright SP 1994 Lack of association of glucocorticoid therapy and retinopathy of prematurity. Arch Pediatr Adolesc Med 148:848-852
24. Ehrenkrantz R 1992 Steroids, chronic lung disease, and retinopathy of prematurity. Pediatrics 90:647-648
25. Rastogi A, Akintorin SM, Bez ML, Morales P, Pildes R 1996 A controlled trial of dexamethasone to prevent bronchopulmonary dysplasia in surfactant-treated infants. Pediatrics 98:204-210
26. Valkova Z 1986 Administration of corticoids in the treatment of retinopathy of prematurity. Cesk Oftalmol 42:267-269
27. Kennedy JE, Todd DA, John E 1997 Premature birth and retinopathy of prematurity. In: Reibaldi A, Di Pietro M, Scuderi, Malerba E (eds) Progress in Retinopathy of Prematurity. Kugler Publications, Amsterdam, pp 25-29
28. The Italian ROP study group 1997 Italian multicenter study on retinopathy of prematurity: the Italian ROP study group. Eur J Pediatr 156:939-943
29. Higgins RD, Mendelsohn AL, DeFeo MJ, Ucsel R, Hendricks-Munoz KD 1998 Antenatal dexamethasone and decreased severity of retinopathy of prematurity. Arch Ophthalmol 116:601-605
30. Smith LEH, Wesolowski E, McLellan A, Kostyk SK, D'Amato R, Sullivan R, D'Amore PA 1994 Oxygen-Induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 35:101-111
31. D'Amato R, Wesolowski E, Smith LEH 1993 Microscopic visualization of the retina by angiography with high molecular weight fluorescein labeled dextrans in the mouse. Microvasc Res 46:135-142
32. Higgins RD, Yu K, Sanders RJ, Nandgaonkar BN, Rotschild T, Rifkin DB 1999 Diltiazem reduces retinal neovascularization in a mouse model of oxygen induced retinopathy. Curr Eye Res 18:20-27
33. Bancroft JD, Cook HC, Sterling RW, Turner DP 1994 Manual of Histological Techniques and Their Diagnostic Application. Churchill Livingstone, Edinburgh, pp 134-136
34. Yeh TF, Lin YJ, Huang CC, Chen YJ, Lin CH, Lin HC, Hsieh WS, Lien YJ 1998 Early dexamethasone therapy in preterm infants: a follow-up study. Pediatrics 101(5):E7
35. Gregoire MC, Lefebvre F, Glorieux J 1998 Health and development outcomes at 18 months in very preterm infants with bronchopulmonary dysplasia. Pediatrics 101:856-860
36. Barks JDE, Post M, Tuor UI 1991 Dexamethasone prevents hypoxic-ischemic brain damage in the neonatal rat. Pediatr Res 29:558-563
37. Pierce EA, Foley ED, Smith LEH 1996 Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity. Arch Ophthalmol 114:1219-1228
38. Pierce EA, Avery RL, Foley ED, Aiello LP, Smith LEH 1995 Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci USA 92:905-909
39. Aiello LP, Pierce EA, Foley ED, Takagi H, Chen H, Riddle L, Ferrara N, King GL, Smith LE 1995 Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci USA 92:1045-1061
40. Robinson GS, Pierce EA, Rook SL, Foley E, Webb R, Smith LE 1996 Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy. Proc Natl Acad Sci USA 93:4851-4856
41. Hammes HP, Brown Lee M, Jonczyk A, Sutter A, Preissner KT 1996 Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization. Nat Med 2:529-533
42. Smith LEH, Kopchick JJ, Chen W, Knapp J, Kinose F, Daley D, Foley E, Smith RG, Schaeffer JM 1997 Essential role of growth hormone in ischemia-induced retinal neovascularization. Science 276:1706-1709
43. Suzuma K, Takagi H, Otani A, Suzuma I, Honda Y 1998 Increased expression of KDR/Flk-1 (VEGFR-2) in murine model of ischemia-induced retinal neovascularization. Microvasc Res 56:183-191
44. Lahat N, Bitterman H, Yaniv N, Kinarty A, Bitterman N 1995 Exposure to hyperbaric oxygen induces tumor necrosis factor-alpha (TNF-alpha) secretion from rat macrophages. Clin Exp Immunol 102:655-659
45. O'Brien-Lander AR, Nelson ME, Cowley Jr BD, Bailey K, Wesselius LJ 1995 Hyperoxia amplifies TNF-alpha production in LPS-stimulated human alveolar macrophages. Am J Respir Cell Mol Biol 12:275-279
46. Shea LM, Beehler C, Schwartz M, Shenkar R, Tuder R, Abraham E 1996 Hyperoxia activates TNF - Kappa B and increases TNF-alpha and IFN-gamma gene expression in mouse pulmonary lymphocytes. J Immunol 157:3902-3908
47. Jensen JC, Pogrebnic HW, Pass HI, Buresh C, Merino MJ, Kauffman D, Venzon D, Langstein HN, Norton JA 1992 Role of tumor necrosis factor in oxygen toxicity. J Appl Physiol 72:1902-1907
48. Yoshida S, Ono M, Shono T, Izumi H, Ishibashi T, Suzuki H, Kuwano M 1997 Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis. Mol Cell Biol 17:4015-4023
49. Joyce DA, Kloda A, Steer JH 1997 Dexamethasone suppresses release of soluble TNF receptors by human monocytes concurrently with TNF-alpha suppression. Immunol Cell Biol 75:345-350
50. Brenner T, Yamin A, Abramsky O, Gallily R 1993 Stimulation of tumor necrosis factor-alpha production by mycoplasmas and inhibition by dexamethasone in cultured astrocytes. Brain Res 608:273-279
51. Waage A, Bakke O 1988 Glucocorticoids suppress the production of tumor necrosis factor by lipopolysaccharide-stimulated human monocytes. Immunology 63:299-302
52. Bruttsand R, Linden M 1996 Cytokine modulation by glucocorticoids: mechanisms and actions in cellular studies. Aliment Pharmacol Ther 10 Suppl 2:81-90
53. Pan M, Wasa M, Ruan U, Souda W 1996 Lipopolysaccharide and tumor necrosis factor stimulate lung microvascular arginine uptake, a response attenuated by dexamethasone. JPEN J Parenter Enteral Nutr 20:50-55
54. LaVail MM, Unoki K, Yasumura D, Matthes MT, Yancopoulos GD, Steinberg RH 1992 Multiple growth factors, cytokines, and neurotrophins rescue photoreceptors from the damaging effects of constant light. Proc Natl Acad Sci USA 89:11249-11253
55. Behar-Cohen FF, Parel JM, Pouliquen Y, Thillaye-Goldenberg B, Goureau O, Heydolph S, Courtois Y, De Kozak Y 1997 Iontophoresis of dexamethasone in the treatment of endotoxin-induced-uveitis in rats. Exp Eye Res 65:533-554
56. Limb GA, Alam A, Earley O, Green W, Chignell AH, Dumonde DC 1994 Distribution of cytokine proteins within epiretinal membranes in proliferative vitreoretinopathy. Curr Eye Res 13:791-798
57. Limb GA, Chignell AH, Green W, LeRoy F, Dumonde DC 1996 Distribution of TNF alpha and its reactive vascular adhesion molecules in fibrovascular membranes of proliferative diabetic retinopathy. Br J Ophthalmol 80:168-173
58. Danis RP, Bingaman DP, Yang Y, Ladd B 1996 Inhibition of preretinal and optic nerve head neovascularization in pigs by intravitreal triamcinolone acetonide. Ophthalmology 103:2099-2104
59. Ishibashi T, Miki K, Sorgente N, Patterson R, Ryan SJ 1985 Effects of intravitreal administration of steroids on experimental subretinal neovascularization in the subhuman primate. Arch Ophthalmol 103:708-711
60. Jarvelainen H, Pelliniemi TT, Ronnemaa T 1985 The stabilizing effect of glucocorticoids on human endothelial cells in culture. Scand J Clin Lab Invest 45:223-228
61. Gyllenstein LJ, Hellstrom BE 1955 Experimental approach to the pathogenesis of retrolental fibroplasia: II. the influence of the developmental maturity in oxygen-induced changes in the mouse eye. Am J Pathol 39:475-488